(3R)-3,6,8-Trihydroxy-7-chlorotetralin-1-one

Details

Top
Internal ID 297d1444-9a90-4d2d-9384-5e328f9afbcd
Taxonomy Benzenoids > Tetralins
IUPAC Name (3R)-7-chloro-3,6,8-trihydroxy-3,4-dihydro-2H-naphthalen-1-one
SMILES (Canonical) C1C(CC(=O)C2=C(C(=C(C=C21)O)Cl)O)O
SMILES (Isomeric) C1[C@H](CC(=O)C2=C(C(=C(C=C21)O)Cl)O)O
InChI InChI=1S/C10H9ClO4/c11-9-7(14)2-4-1-5(12)3-6(13)8(4)10(9)15/h2,5,12,14-15H,1,3H2/t5-/m1/s1
InChI Key KJOZIJYDPJBYLK-RXMQYKEDSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H9ClO4
Molecular Weight 228.63 g/mol
Exact Mass 228.0189365 g/mol
Topological Polar Surface Area (TPSA) 77.80 Ų
XlogP 1.50
Atomic LogP (AlogP) 1.24
H-Bond Acceptor 4
H-Bond Donor 3
Rotatable Bonds 0

Synonyms

Top
(3R)-3,6,8-Trihydroxy-7-chlorotetralin-1-one

2D Structure

Top
2D Structure of (3R)-3,6,8-Trihydroxy-7-chlorotetralin-1-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9846 98.46%
Caco-2 + 0.6835 68.35%
Blood Brain Barrier - 0.5750 57.50%
Human oral bioavailability + 0.6571 65.71%
Subcellular localzation Mitochondria 0.6811 68.11%
OATP2B1 inhibitior - 0.8575 85.75%
OATP1B1 inhibitior + 0.9077 90.77%
OATP1B3 inhibitior + 0.9311 93.11%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.8500 85.00%
BSEP inhibitior - 0.9380 93.80%
P-glycoprotein inhibitior - 0.9790 97.90%
P-glycoprotein substrate - 0.9409 94.09%
CYP3A4 substrate - 0.5082 50.82%
CYP2C9 substrate - 0.8046 80.46%
CYP2D6 substrate - 0.7911 79.11%
CYP3A4 inhibition + 0.6966 69.66%
CYP2C9 inhibition + 0.6085 60.85%
CYP2C19 inhibition - 0.6124 61.24%
CYP2D6 inhibition - 0.7776 77.76%
CYP1A2 inhibition + 0.7473 74.73%
CYP2C8 inhibition - 0.9211 92.11%
CYP inhibitory promiscuity + 0.5378 53.78%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.7380 73.80%
Carcinogenicity (trinary) Non-required 0.5460 54.60%
Eye corrosion - 0.9798 97.98%
Eye irritation + 0.9415 94.15%
Skin irritation + 0.6111 61.11%
Skin corrosion - 0.9240 92.40%
Ames mutagenesis + 0.5200 52.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7164 71.64%
Micronuclear + 0.5433 54.33%
Hepatotoxicity + 0.6553 65.53%
skin sensitisation + 0.5381 53.81%
Respiratory toxicity + 0.5889 58.89%
Reproductive toxicity + 0.7444 74.44%
Mitochondrial toxicity + 0.7125 71.25%
Nephrotoxicity - 0.6575 65.75%
Acute Oral Toxicity (c) I 0.3518 35.18%
Estrogen receptor binding + 0.5613 56.13%
Androgen receptor binding + 0.6858 68.58%
Thyroid receptor binding + 0.5221 52.21%
Glucocorticoid receptor binding + 0.8575 85.75%
Aromatase binding - 0.7275 72.75%
PPAR gamma + 0.7378 73.78%
Honey bee toxicity - 0.8538 85.38%
Biodegradation - 0.7750 77.50%
Crustacea aquatic toxicity + 0.5900 59.00%
Fish aquatic toxicity + 0.9760 97.60%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.21% 91.11%
CHEMBL217 P14416 Dopamine D2 receptor 95.43% 95.62%
CHEMBL2581 P07339 Cathepsin D 91.69% 98.95%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 90.84% 94.45%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 87.28% 95.56%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 85.37% 90.71%
CHEMBL1293249 Q13887 Kruppel-like factor 5 82.09% 86.33%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 81.90% 99.15%
CHEMBL4208 P20618 Proteasome component C5 81.22% 90.00%

Cross-Links

Top
PubChem 102258990
NPASS NPC229857
LOTUS LTS0026928
wikiData Q77568981